Breaking News Instant updates and real-time market news.

TCRR

TCR2 Therapeutics

$16.20

-2.5 (-13.37%)

04:55
04/25/19
04/25
04:55
04/25/19
04:55

TCR2 Therapeutics management to meet with Jefferies

Meeting to be held in New York on April 25 hosted by Jefferies.

  • 25

    Apr

TCRR TCR2 Therapeutics
$16.20

-2.5 (-13.37%)

03/11/19
WEDB
03/11/19
INITIATION
Target $28
WEDB
Outperform
TCR2 Therapeutics initiated with an Outperform at Wedbush
Wedbush analyst David Nierengarten initiated TCR2 Therapeutics with an Outperform rating and $28 price target. In a research note to investors, Nierengarten contends that shares are undervalued based onhis positive outlook on the company's potentially best-in-class CAR-T cell platform, which is developing T-cell receptor Fusion Construct T cells, or TRuC-T cells,for both solid tumor and hematologic malignancies. To date, the platform has generated one clinical and two near-clinicalproduct candidates, including TC-210, currently in Ph 1 for mesothelin-expressing solid tumors, and TC-110 and TC-220, which are both in IND-enabling studies for CD19-positive B-cell malignancies and MUC16-expressing solid tumors.
03/11/19
JEFF
03/11/19
INITIATION
Target $31
JEFF
Buy
Jefferies starts TCR2 Therapeutics with Buy rating, $31 price target
Jefferies analyst Biren Amin initiated coverage of TCR2 Therapeutics with a Buy rating and $31 price target. The company is developing a "broad pipeline" centered on its TRuC technology that endows certain advantageous properties to T-cells for targeting solid tumors, where CAR-Ts have not seen much success, Amin tells investors in a research note. While early in development, the analyst believes TCR2 may offer a differentiated approach.
03/11/19
LEER
03/11/19
INITIATION
Target $27
LEER
Outperform
TCR2 Therapeutics initiated with an Outperform at SVB Leerink
SVB Leerink analyst Jonathan Chang initiated TCR2 Therapeutics with an Outperform rating and $27 price target. In a research note to investors, Chang says he has received positive feedback from MEDACorp Key Opinion Leaders on the company's T-Cell Receptor Fusion Construct pipeline based on the preclinical data to date that highlights the potential of TCR2's approach. The analyst maintains a positive long-term view of the stock based on the experienced management team and potentially transformative platform with broad therapeutic applicability.
03/11/19
03/11/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. TCR2 Therapeutics (TCRR) initiated with an Outperform at SVB Leerink, Wedbush, and BMO Capital, while being initiated with a Buy at Jefferies. 2. Barings BDC (BBDC) resumed with an Outperform at Wells Fargo. 3. Avedro (AVDR) initiated with an Overweight at JPMorgan while being initiated with an Outperform at SVB Leerink and Cowen. 4. Anchiano Therapeutics (ANCN) initiated with a Buy at Ladenburg and an Outperform at Oppenheimer. 5. CytomX Therapeutics (CTMX) initiated with an Overweight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:37
06/25/19
06/25
17:37
06/25/19
17:37
Hot Stocks
FedEx says intends to substantially grow e-commerce business »

Sees FedEx Freight will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

CNX

CNX Resources

$6.83

-0.345 (-4.81%)

17:36
06/25/19
06/25
17:36
06/25/19
17:36
Hot Stocks
CNX Resources director Bernard Lanigan purchases 36,200 shares of company stock »

CNX Resources director…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$24.96

0.21 (0.85%)

17:32
06/25/19
06/25
17:32
06/25/19
17:32
Hot Stocks
TechnipFMC confirms settlement with U.S., Brazilian enforcement authorities »

TechnipFMC has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

MO

Altria Group

$48.80

0.31 (0.64%)

, BTI

British American Tobacco

$35.76

0.56 (1.59%)

17:25
06/25/19
06/25
17:25
06/25/19
17:25
Periodicals
San Francisco votes to ban sale of e-cigarettes, AP reports »

San Francisco, California…

MO

Altria Group

$48.80

0.31 (0.64%)

BTI

British American Tobacco

$35.76

0.56 (1.59%)

PM

Philip Morris

$78.85

1.02 (1.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$53.69

0.57 (1.07%)

17:16
06/25/19
06/25
17:16
06/25/19
17:16
Recommendations
CVS Health analyst commentary at Tigress Financial »

Tigress Financial sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTI

TechnipFMC

$24.96

0.21 (0.85%)

17:15
06/25/19
06/25
17:15
06/25/19
17:15
Hot Stocks
TechnipFMC, subsidiary to pay $296M to resolve foreign bribery charges »

TechnipFMC and its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 27

    Aug

ORRF

Orrstown Financial

$21.93

0.22 (1.01%)

17:11
06/25/19
06/25
17:11
06/25/19
17:11
Hot Stocks
Orrstown Financial names Thomas Brugger EVP and CFO »

Orrstown Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

17:07
06/25/19
06/25
17:07
06/25/19
17:07
Hot Stocks
Micron says it has mitigated 90% of China tariff impact »

Says U.S. tariffs on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AGN

Allergan

$162.60

32.95 (25.41%)

, ABBV

AbbVie

$65.63

-12.78 (-16.30%)

17:07
06/25/19
06/25
17:07
06/25/19
17:07
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

Stocks muddled through a…

AGN

Allergan

$162.60

32.95 (25.41%)

ABBV

AbbVie

$65.63

-12.78 (-16.30%)

TMUS

T-Mobile

$74.56

-0.98 (-1.30%)

S

Sprint

$6.82

-0.04 (-0.58%)

DISH

Dish

$37.80

-0.79 (-2.05%)

LEN

Lennar

$48.24

-3.17 (-6.17%)

FDX

FedEx

$156.00

-4.88 (-3.03%)

UPS

UPS

$97.11

-2.58 (-2.59%)

FB

Facebook

$188.87

-3.69 (-1.92%)

PYX

Pyxus

$17.06

3.635 (27.09%)

GRUB

GrubHub

$76.01

3.96 (5.50%)

ALDX

Aldeyra

$6.21

-0.87 (-12.29%)

W

Wayfair

$144.54

-7.925 (-5.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 27

    Jun

  • 28

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

  • 24

    Jul

  • 30

    Jul

  • 31

    Jul

  • 16

    Sep

  • 13

    Nov

AITB

AIT Therapeutics

$5.33

0.06 (1.14%)

17:05
06/25/19
06/25
17:05
06/25/19
17:05
Hot Stocks
AIT Therapeutics plans to file PMA submission with FDA for PPHN with AirNOvent »

On track to file a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

17:03
06/25/19
06/25
17:03
06/25/19
17:03
Earnings
Micron sees Q4 EPS 45c +/- 7c, consensus 78c »

Sees Q4 revenue $4.5B +/-…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AITB

AIT Therapeutics

$5.33

0.06 (1.14%)

17:00
06/25/19
06/25
17:00
06/25/19
17:00
Earnings
AIT Therapeutics reports Q4 EPS (49c), consensus 28c »

Reports Q4 revenue $7.7M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

16:48
06/25/19
06/25
16:48
06/25/19
16:48
Hot Stocks
Micron says it can resume shipping a certain subset of products to Huawei »

Says expects healthy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

AVAV

AeroVironment

$61.41

-0.52 (-0.84%)

16:42
06/25/19
06/25
16:42
06/25/19
16:42
Hot Stocks
AeroVironment down 9.5% to $55.50 after Q4 results, FY20 guidance »

The midpoint of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

BBVA

Banco Bilbao

$5.52

-0.05 (-0.90%)

16:40
06/25/19
06/25
16:40
06/25/19
16:40
Syndicate
Breaking Syndicate news story on Banco Bilbao »

Banco Bilbao files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

CRTO

Criteo

$18.00

-0.05 (-0.28%)

16:39
06/25/19
06/25
16:39
06/25/19
16:39
Hot Stocks
Criteo COO Mollie Spilman to leave company »

Criteo S.A. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KHC

Kraft Heinz

$30.68

0.17 (0.56%)

16:37
06/25/19
06/25
16:37
06/25/19
16:37
Hot Stocks
Kraft Heinz accelerates new CEO start date to June 25 »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$144.12

-5.99 (-3.99%)

16:34
06/25/19
06/25
16:34
06/25/19
16:34
Periodicals
Spotify chief revenue officer Brian Benedik to depart, The Information reports »

Spotify's chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:34
06/25/19
06/25
16:34
06/25/19
16:34
General news
API crude inventories for week of June 21 »

API reports that crude…

GBCI

Glacier Bancorp

$39.23

-0.06 (-0.15%)

16:34
06/25/19
06/25
16:34
06/25/19
16:34
Hot Stocks
Glacier Bancorp raises dividend to 27c from 26c »

Glacier Bancorp declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

NSRGY

Nestle

$0.00

(0.00%)

, NVS

Novartis

$92.37

-0.41 (-0.44%)

16:33
06/25/19
06/25
16:33
06/25/19
16:33
Periodicals
Nestle, Novartis among multinationals at risk of London trading ban, WSJ says »

Trading in…

NSRGY

Nestle

$0.00

(0.00%)

NVS

Novartis

$92.37

-0.41 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

DRRX

Durect

$0.67

0.0422 (6.72%)

16:31
06/25/19
06/25
16:31
06/25/19
16:31
Hot Stocks
Durect receives approval to transfer to Nasdaq Capital Market »

Durect Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COWN

Cowen Group

$16.65

0.36 (2.21%)

16:31
06/25/19
06/25
16:31
06/25/19
16:31
Hot Stocks
Cowen Group names CEO Jeffrey Solomon as chairman of the board »

Cowen is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INXN

Interxion

$75.06

-0.51 (-0.67%)

16:30
06/25/19
06/25
16:30
06/25/19
16:30
Syndicate
Interxion files to sell 4M newly issued ordinary shares »

Citigroup, Barclays, BofA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
06/25/19
06/25
16:30
06/25/19
16:30
Options
Preliminary option volume of 17.5M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.